Stay updated on Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.3%
    Check dated 2024-09-04T05:03:03.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-08-13T23:44:42.000Z thumbnail image
  5. Check
    31 days ago
    No Change Detected
  6. Check
    38 days ago
    Change Detected
    Summary
    The status of the drug has changed to 'Terminated' as the sponsor is no longer supporting it, replacing the previous status of 'Active, not recruiting'.
    Difference
    2%
    Check dated 2024-07-30T22:38:14.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The website has updated its status from 'Recruiting' to 'Active, not recruiting' as of July 25, 2024.
    Difference
    1%
    Check dated 2024-07-25T17:16:10.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.
    Difference
    6%
    Check dated 2024-07-23T14:49:31.000Z thumbnail image
  9. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.3%
    Check dated 2024-07-16T06:31:00.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.